4'-Methyl-α-pyrrolidinohexiophenone
Clinical data | |
---|---|
Other names | MPHP |
Legal status | |
Legal status |
|
Identifiers | |
| |
JSmol) | |
Chirality | Racemic mixture |
| |
|
4'-Methyl-α-pyrrolidinohexiophenone (MPHP) is a
aryl, ketone and pyrrolidinyl groups are held constant, while the alkyl backbone can be varied anywhere between three and as many as seven carbons,[4] with highest potency usually seen with the pentyl or isohexyl backbone, and a variety of substituents are tolerated on the aromatic ring.[5]
In 2010 a group of researchers from the Institute of Forensic Medicine, University Hospital Jena, Germany concluded that MPHP can lead to serious poisoning with toxic liver damage and rhabdomyolysis.[6]
Legality
In the United States, MPHP is a
Schedule I Controlled Substance.[7] Sweden's public health agency suggested to classify MPHP as narcotic on June 1, 2015.[8]
See also
References
- PMID 12726846.
- PMID 19470220.
- PMID 21444164.
- ^ GB patent 1149366, "α-substituted-ketones and processes for their preparation."
- PMID 16480278.
- PMID 21444164.
- ^ "Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, α-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-α-PVP in Schedule I". Drug Enforcement Administration. Archived from the original on 2021-04-30. Retrieved 2019-07-29.
- ^ "23 nya ämnen kan klassas som narkotika eller hälsofarlig vara". Retrieved 29 June 2015.